- Round ID
- FR-00070
- Stage
- Series B
- Round name
- Series B
- Amount
- $24M
Dated funding evidence
Biofidelity
Series B · $24M · 2024-04-01
Reported round$24MSeries B
- Disclosure date
- 2024-04-01
- Reported currency
- USD
- Companies House
- 11830661
- Evidence sources
- 1
Company
BiofidelityCH 118306612024-04-01Series B$24M
Resolved investor records
Agilent TechnologiesInvestorOctopus VenturesInvestorBlueYard CapitalInvestorLongwall VenturesInvestor
1 additional source-listed name is retained in the record fields below but not linked without an exact canonical match.
Record fields
What the source states
Amounts, currency, stage and investor names are preserved as reported. No FX conversion, valuation inference or current-holding claim is added.
- Lead investors
- not specified in source
- Other investors
- Agilent Technologies, Octopus Ventures, BlueYard Capital, Longwall Ventures
- Source layers
- VC research snapshot, Live Chris T D1
- Snapshot
- 2026-08-15
Named evidence
Source trail
This page is published only when the record has a resolved company, disclosure date, round stage and at least one retained source URL.